Assessing the Impact of Aldose Reductase (ALR2) Regulatory Gene Polymorphism in Diabetic Retinopathy Patients
Diabetic retinopathy, a serious complication of diabetes, may be influenced by genetic factors, including the Aldose Reductase (ALR2) gene polymorphism. There is a crucial need to understand how the polymorphism in the ALR2 gene contributes to diabetic retinopathy. This study aimed to explore and e...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
QAASPA Publisher
2024-12-01
|
| Series: | BioMed Target Journal |
| Subjects: | |
| Online Access: | https://qaaspa.com/index.php/bmtj/article/view/9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841546210752593920 |
|---|---|
| author | Hadiza Rabe Musa Amina Rabe Musa Yahuza Gimba Muhammed Usman Salisu Batagarawa Aminu Ibrahim |
| author_facet | Hadiza Rabe Musa Amina Rabe Musa Yahuza Gimba Muhammed Usman Salisu Batagarawa Aminu Ibrahim |
| author_sort | Hadiza Rabe Musa |
| collection | DOAJ |
| description | Diabetic retinopathy, a serious complication of diabetes, may be influenced by genetic factors, including the Aldose Reductase (ALR2) gene polymorphism. There is a crucial need to understand how the polymorphism in the ALR2 gene contributes to diabetic retinopathy. This study aimed to explore and evaluate the impact of ALR2 gene polymorphism on diabetic retinopathy, alongside assessing inflammatory markers and antioxidant status among diabetic patients residing in Kano State, Nigeria. In this study, 40 participants were enrolled; the participants were divided into 4 groups, with three test groups (diabetes mellitus, cataract, and diabetic retinopathy groups) and the control group. The investigation encompassed and incorporated the prevalence of the SNP C(-106)T polymorphism within the ALR2 promoter region, in combination with the assessment of inflammatory markers (C-reactive protein [CRP] and high-sensitivity C-reactive protein [hsCRP]), malondialdehyde (MDA) levels, vitamin A and aldose reductase concentrations. The findings revealed a 6.7% prevalence of the SNP C(-106)T polymorphism. Fasting blood glucose and HbA1c levels were significantly (p<0.05) lower in the control group compared to the diabetic, cataract, and diabetic retinopathy groups. The result also revealed elevated CRP, hsCRP, and MDA levels in the study groups compared to the control group. However, weak negative correlation values were found between vitamin A levels and ALR2 concentrations, indicating a complex relationship that warrants further investigation. Molecular analysis unveiled single nucleotide polymorphisms (SNPs) at nucleotide position -106 within two samples (DR6 and D3). This followed the successful amplification of the specified AR2 gene DNA segment through a Polymerase Chain Reaction (PCR) methodology. Subsequently, DNA sequencing was performed using the ABI Prism BigDyeTM Terminator Cycle Sequencing Ready Reaction Kit on the ABI PrismTM 3730/3730XL DNA Sequencer. In addition, there was no significant (p > 0.05) observed correlation between ALR2 and MDA (r= 0.026) or CRP (r= -0.077). The study identified a 6.7% prevalence of ALR2 gene polymorphism in diabetic retinopathy patients, alongside elevated inflammatory markers and MDA levels. Moreover, in the present finding, all control group had the C (CC genotype) allele, while the study group had 90% C allele and 10% T allele. The T allele showed no significant association with DR 1.00 (OR 95% CI: 0.127-7.893; p:1.00). However, Additional research with larger sample sizes is warranted to comprehensively investigate the implications of the SNP C(-106)T polymorphism at the ALR2 promoter region. |
| format | Article |
| id | doaj-art-6c5e77dbd2dc467dba932600ce344610 |
| institution | Kabale University |
| issn | 2960-1428 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | QAASPA Publisher |
| record_format | Article |
| series | BioMed Target Journal |
| spelling | doaj-art-6c5e77dbd2dc467dba932600ce3446102025-01-10T21:54:26ZengQAASPA PublisherBioMed Target Journal2960-14282024-12-0122314510.59786/bmtj.2239Assessing the Impact of Aldose Reductase (ALR2) Regulatory Gene Polymorphism in Diabetic Retinopathy PatientsHadiza Rabe Musa0https://orcid.org/0009-0001-1222-8745Amina Rabe Musa1https://orcid.org/0009-0001-1838-0780Yahuza Gimba Muhammed2https://orcid.org/0000-0002-1861-2713Usman Salisu Batagarawa3https://orcid.org/0000-0003-2506-8928Aminu Ibrahim4https://orcid.org/0000-0003-1484-7192Department of Biochemistry, Faculty of Basic Medical Sciences, Bayero University Kano, Kano, 700006, NigeriaDepartment of Biological Sciences, Faculty of Science, Usmanu Danfodiyo University Sokoto, Sokoto, 840104, NigeriaDepartment of Biochemistry, Faculty of Basic Medical Sciences, Bayero University Kano, Kano, 700006, NigeriaDepartment of Biological Sciences, Faculty of Science, Usmanu Danfodiyo University Sokoto, Sokoto, 840104, NigeriaDepartment of Biochemistry, Faculty of Basic Medical Sciences, Bayero University Kano, Kano, 700006, NigeriaDiabetic retinopathy, a serious complication of diabetes, may be influenced by genetic factors, including the Aldose Reductase (ALR2) gene polymorphism. There is a crucial need to understand how the polymorphism in the ALR2 gene contributes to diabetic retinopathy. This study aimed to explore and evaluate the impact of ALR2 gene polymorphism on diabetic retinopathy, alongside assessing inflammatory markers and antioxidant status among diabetic patients residing in Kano State, Nigeria. In this study, 40 participants were enrolled; the participants were divided into 4 groups, with three test groups (diabetes mellitus, cataract, and diabetic retinopathy groups) and the control group. The investigation encompassed and incorporated the prevalence of the SNP C(-106)T polymorphism within the ALR2 promoter region, in combination with the assessment of inflammatory markers (C-reactive protein [CRP] and high-sensitivity C-reactive protein [hsCRP]), malondialdehyde (MDA) levels, vitamin A and aldose reductase concentrations. The findings revealed a 6.7% prevalence of the SNP C(-106)T polymorphism. Fasting blood glucose and HbA1c levels were significantly (p<0.05) lower in the control group compared to the diabetic, cataract, and diabetic retinopathy groups. The result also revealed elevated CRP, hsCRP, and MDA levels in the study groups compared to the control group. However, weak negative correlation values were found between vitamin A levels and ALR2 concentrations, indicating a complex relationship that warrants further investigation. Molecular analysis unveiled single nucleotide polymorphisms (SNPs) at nucleotide position -106 within two samples (DR6 and D3). This followed the successful amplification of the specified AR2 gene DNA segment through a Polymerase Chain Reaction (PCR) methodology. Subsequently, DNA sequencing was performed using the ABI Prism BigDyeTM Terminator Cycle Sequencing Ready Reaction Kit on the ABI PrismTM 3730/3730XL DNA Sequencer. In addition, there was no significant (p > 0.05) observed correlation between ALR2 and MDA (r= 0.026) or CRP (r= -0.077). The study identified a 6.7% prevalence of ALR2 gene polymorphism in diabetic retinopathy patients, alongside elevated inflammatory markers and MDA levels. Moreover, in the present finding, all control group had the C (CC genotype) allele, while the study group had 90% C allele and 10% T allele. The T allele showed no significant association with DR 1.00 (OR 95% CI: 0.127-7.893; p:1.00). However, Additional research with larger sample sizes is warranted to comprehensively investigate the implications of the SNP C(-106)T polymorphism at the ALR2 promoter region.https://qaaspa.com/index.php/bmtj/article/view/9diabetic retinopathyalr2 gene polymorphisminflammatory markersantioxidant status |
| spellingShingle | Hadiza Rabe Musa Amina Rabe Musa Yahuza Gimba Muhammed Usman Salisu Batagarawa Aminu Ibrahim Assessing the Impact of Aldose Reductase (ALR2) Regulatory Gene Polymorphism in Diabetic Retinopathy Patients BioMed Target Journal diabetic retinopathy alr2 gene polymorphism inflammatory markers antioxidant status |
| title | Assessing the Impact of Aldose Reductase (ALR2) Regulatory Gene Polymorphism in Diabetic Retinopathy Patients |
| title_full | Assessing the Impact of Aldose Reductase (ALR2) Regulatory Gene Polymorphism in Diabetic Retinopathy Patients |
| title_fullStr | Assessing the Impact of Aldose Reductase (ALR2) Regulatory Gene Polymorphism in Diabetic Retinopathy Patients |
| title_full_unstemmed | Assessing the Impact of Aldose Reductase (ALR2) Regulatory Gene Polymorphism in Diabetic Retinopathy Patients |
| title_short | Assessing the Impact of Aldose Reductase (ALR2) Regulatory Gene Polymorphism in Diabetic Retinopathy Patients |
| title_sort | assessing the impact of aldose reductase alr2 regulatory gene polymorphism in diabetic retinopathy patients |
| topic | diabetic retinopathy alr2 gene polymorphism inflammatory markers antioxidant status |
| url | https://qaaspa.com/index.php/bmtj/article/view/9 |
| work_keys_str_mv | AT hadizarabemusa assessingtheimpactofaldosereductasealr2regulatorygenepolymorphismindiabeticretinopathypatients AT aminarabemusa assessingtheimpactofaldosereductasealr2regulatorygenepolymorphismindiabeticretinopathypatients AT yahuzagimbamuhammed assessingtheimpactofaldosereductasealr2regulatorygenepolymorphismindiabeticretinopathypatients AT usmansalisubatagarawa assessingtheimpactofaldosereductasealr2regulatorygenepolymorphismindiabeticretinopathypatients AT aminuibrahim assessingtheimpactofaldosereductasealr2regulatorygenepolymorphismindiabeticretinopathypatients |